Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Galasko

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Neurology and Neuroscience Reports|March 20, 2002
Lewy bodies and dementiaD Galasko
The Western Journal of Medicine|May 19, 1998
The role of apolipoprotein E testing in the diagnosis of Alzheimer's diseaseD Galasko
Journal of Neural Transmission. Supplementum|August 13, 1998
Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's diseaseD Galasko
Clinics in Geriatric Medicine|May 26, 2001
New approaches to diagnose and treat Alzheimer's disease: a glimpse of the futureD Galasko
Archives of Neurology|June 16, 1999
Cerebrospinal fluid opens a window on Alzheimer diseaseD Galasko
Neurobiology of Aging|April 29, 1998
CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?D Galasko
Journal of Molecular Neuroscience : MN|January 31, 2002
Biological markers and the treatment of Alzheimer's diseaseD Galasko
Drugs & Aging|August 1, 1995
Adjunctive therapy in patients with Alzheimer's disease. A practical approachJ Corey-Bloom, D Galasko
Current Opinion in Neurology and Neurosurgery|December 1, 1992
Lewy body diseaseL A Hansen, D Galasko
Archives of Neurology|January 1, 1986
Ataxic hemiparesis with intact sensory modalitiesJ Schleimer, D Galasko, B J Stern
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Neurology and Neuroscience Reports|March 20, 2002
Lewy bodies and dementiaD Galasko
The Western Journal of Medicine|May 19, 1998
The role of apolipoprotein E testing in the diagnosis of Alzheimer's diseaseD Galasko
Journal of Neural Transmission. Supplementum|August 13, 1998
Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's diseaseD Galasko
Clinics in Geriatric Medicine|May 26, 2001
New approaches to diagnose and treat Alzheimer's disease: a glimpse of the futureD Galasko
Archives of Neurology|June 16, 1999
Cerebrospinal fluid opens a window on Alzheimer diseaseD Galasko
Neurobiology of Aging|April 29, 1998
CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?D Galasko
Journal of Molecular Neuroscience : MN|January 31, 2002
Biological markers and the treatment of Alzheimer's diseaseD Galasko
Drugs & Aging|August 1, 1995
Adjunctive therapy in patients with Alzheimer's disease. A practical approachJ Corey-Bloom, D Galasko
Current Opinion in Neurology and Neurosurgery|December 1, 1992
Lewy body diseaseL A Hansen, D Galasko
Archives of Neurology|January 1, 1986
Ataxic hemiparesis with intact sensory modalitiesJ Schleimer, D Galasko, B J Stern
Pageof 11